ELIZABETH MEDINA: Open Payments
NPI 1538466529 · JENKINTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,038 in 51 payments from 15 companies in 2025. Trend: 2023 $792 · 2024 $1,066 · 2025 $1,038
Food & beverage: $1,038
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $291 |
| Kestra Medical Technology Services, Inc. | 5 | $156 |
| Alnylam Pharmaceuticals Inc. | 5 | $99 |
| AstraZeneca Pharmaceuticals LP | 4 | $94 |
| Abbott Laboratories | 3 | $65 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $63 |
| Boston Scientific Corporation | 1 | $52 |
| Philips North America LLC | 2 | $48 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
Products named: LEQVIO, Assure WCD, ONPATTRO, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, LifeVest, FARXIGA, CDS - MCT/CEM Monitoring, VERQUVO.
Industry payments across PA — which companies pay providers there.
